Eventide Asset Management, LLC Catalyst Biosciences, Inc. Transaction History

Eventide Asset Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 29, 2020	SELL	$4.52 - $7.91 $2.09 Million - $3.66 Million	-462,852 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$7.67 - $9.96 $1.66 Million - $2.16 Million	216,852 Added 88.15%	462,852 $3.75 Million
Q2 2018 Aug 14, 2018	BUY	$9.11 - $28.88 $2.24 Million - $7.1 Million	246,000 New	246,000 $2.87 Million

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Eventide Asset Management, LLC with notifications on news.